Alpha- Antitrypsin Deficiency Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 CT-2009
1.2.3 POL-6014
1.2.4 ARO-AAT
1.2.5 ALNAAT-02
1.2.6 Others
1.3 Market by Application
1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Perspective (2017-2028)
2.2 Alpha- Antitrypsin Deficiency Treatment Growth Trends by Region
2.2.1 Alpha- Antitrypsin Deficiency Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Region (2017-2022)
2.2.3 Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Region (2023-2028)
2.3 Alpha- Antitrypsin Deficiency Treatment Market Dynamics
2.3.1 Alpha- Antitrypsin Deficiency Treatment Industry Trends
2.3.2 Alpha- Antitrypsin Deficiency Treatment Market Drivers
2.3.3 Alpha- Antitrypsin Deficiency Treatment Market Challenges
2.3.4 Alpha- Antitrypsin Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Revenue
3.1.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Revenue (2017-2022)
3.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha- Antitrypsin Deficiency Treatment Revenue
3.4 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio
3.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha- Antitrypsin Deficiency Treatment Revenue in 2021
3.5 Alpha- Antitrypsin Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Alpha- Antitrypsin Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type
4.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Type (2017-2022)
4.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Type (2023-2028)
5 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application
5.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Application (2017-2022)
5.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size (2017-2028)
6.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type
6.2.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)
6.2.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028)
6.2.3 North America Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2017-2028)
6.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application
6.3.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)
6.3.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028)
6.3.3 North America Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2017-2028)
6.4 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country
6.4.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022)
6.4.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size (2017-2028)
7.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type
7.2.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)
7.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028)
7.2.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2017-2028)
7.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application
7.3.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)
7.3.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028)
7.3.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2017-2028)
7.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country
7.4.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022)
7.4.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size (2017-2028)
8.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size (2017-2028)
9.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type
9.2.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2017-2028)
9.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application
9.3.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2017-2028)
9.4 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country
9.4.1 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size (2017-2028)
10.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Adverum Biotechnologies, Inc.
11.1.1 Adverum Biotechnologies, Inc. Company Details
11.1.2 Adverum Biotechnologies, Inc. Business Overview
11.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.1.4 Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.1.5 Adverum Biotechnologies, Inc. Recent Developments
11.2 Alnylam Pharmaceuticals, Inc.
11.2.1 Alnylam Pharmaceuticals, Inc. Company Details
11.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.2.5 Alnylam Pharmaceuticals, Inc. Recent Developments
11.3 Applied Genetic Technologies Corporation
11.3.1 Applied Genetic Technologies Corporation Company Details
11.3.2 Applied Genetic Technologies Corporation Business Overview
11.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
11.3.4 Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.3.5 Applied Genetic Technologies Corporation Recent Developments
11.4 Arrowhead Pharmaceuticals, Inc.
11.4.1 Arrowhead Pharmaceuticals, Inc. Company Details
11.4.2 Arrowhead Pharmaceuticals, Inc. Business Overview
11.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.4.4 Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.4.5 Arrowhead Pharmaceuticals, Inc. Recent Developments
11.5 Carolus Therapeutics, Inc.
11.5.1 Carolus Therapeutics, Inc. Company Details
11.5.2 Carolus Therapeutics, Inc. Business Overview
11.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.5.4 Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.5.5 Carolus Therapeutics, Inc. Recent Developments
11.6 Cevec Pharmaceuticals GmbH
11.6.1 Cevec Pharmaceuticals GmbH Company Details
11.6.2 Cevec Pharmaceuticals GmbH Business Overview
11.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Introduction
11.6.4 Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.6.5 Cevec Pharmaceuticals GmbH Recent Developments
11.7 Dicerna Pharmaceuticals, Inc.
11.7.1 Dicerna Pharmaceuticals, Inc. Company Details
11.7.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.7.4 Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.7.5 Dicerna Pharmaceuticals, Inc. Recent Developments
11.8 Digna Biotech, S.L.
11.8.1 Digna Biotech, S.L. Company Details
11.8.2 Digna Biotech, S.L. Business Overview
11.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Introduction
11.8.4 Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.8.5 Digna Biotech, S.L. Recent Developments
11.9 Editas Medicine, Inc.
11.9.1 Editas Medicine, Inc. Company Details
11.9.2 Editas Medicine, Inc. Business Overview
11.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.9.4 Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.9.5 Editas Medicine, Inc. Recent Developments
11.10 Grifols, S.A.
11.10.1 Grifols, S.A. Company Details
11.10.2 Grifols, S.A. Business Overview
11.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Introduction
11.10.4 Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.10.5 Grifols, S.A. Recent Developments
11.11 Inhibrx
11.11.1 Inhibrx Company Details
11.11.2 Inhibrx Business Overview
11.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Introduction
11.11.4 Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.11.5 Inhibrx Recent Developments
11.12 Intellia Therapeutics, Inc.
11.12.1 Intellia Therapeutics, Inc. Company Details
11.12.2 Intellia Therapeutics, Inc. Business Overview
11.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.12.4 Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.12.5 Intellia Therapeutics, Inc. Recent Developments
11.13 International Stem Cell Corporation
11.13.1 International Stem Cell Corporation Company Details
11.13.2 International Stem Cell Corporation Business Overview
11.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
11.13.4 International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.13.5 International Stem Cell Corporation Recent Developments
11.14 Ionis Pharmaceuticals, Inc.
11.14.1 Ionis Pharmaceuticals, Inc. Company Details
11.14.2 Ionis Pharmaceuticals, Inc. Business Overview
11.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.14.4 Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.14.5 Ionis Pharmaceuticals, Inc. Recent Developments
11.15 Kamada Ltd.
11.15.1 Kamada Ltd. Company Details
11.15.2 Kamada Ltd. Business Overview
11.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
11.15.4 Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.15.5 Kamada Ltd. Recent Developments
11.16 Polyphor Ltd.
11.16.1 Polyphor Ltd. Company Details
11.16.2 Polyphor Ltd. Business Overview
11.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
11.16.4 Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.16.5 Polyphor Ltd. Recent Developments
11.17 ProMetic Life Sciences Inc.
11.17.1 ProMetic Life Sciences Inc. Company Details
11.17.2 ProMetic Life Sciences Inc. Business Overview
11.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.17.4 ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.17.5 ProMetic Life Sciences Inc. Recent Developments
11.18 rEVO Biologics, Inc.
11.18.1 rEVO Biologics, Inc. Company Details
11.18.2 rEVO Biologics, Inc. Business Overview
11.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.18.4 rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.18.5 rEVO Biologics, Inc. Recent Developments
11.19 Sangamo BioSciences, Inc.
11.19.1 Sangamo BioSciences, Inc. Company Details
11.19.2 Sangamo BioSciences, Inc. Business Overview
11.19.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.19.4 Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
11.19.5 Sangamo BioSciences, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of CT-2009
Table 3. Key Players of POL-6014
Table 4. Key Players of ARO-AAT
Table 5. Key Players of ALNAAT-02
Table 6. Key Players of Others
Table 7. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Region (2017-2022)
Table 11. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Region (2023-2028)
Table 13. Alpha- Antitrypsin Deficiency Treatment Market Trends
Table 14. Alpha- Antitrypsin Deficiency Treatment Market Drivers
Table 15. Alpha- Antitrypsin Deficiency Treatment Market Challenges
Table 16. Alpha- Antitrypsin Deficiency Treatment Market Restraints
Table 17. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players (2017-2022)
Table 19. Global Top Alpha- Antitrypsin Deficiency Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha- Antitrypsin Deficiency Treatment as of 2021)
Table 20. Ranking of Global Top Alpha- Antitrypsin Deficiency Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Alpha- Antitrypsin Deficiency Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
Table 24. Date of Enter into Alpha- Antitrypsin Deficiency Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Application (2017-2022)
Table 32. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Application (2023-2028)
Table 34. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 64. Adverum Biotechnologies, Inc. Company Details
Table 65. Adverum Biotechnologies, Inc. Business Overview
Table 66. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 67. Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 68. Adverum Biotechnologies, Inc. Recent Developments
Table 69. Alnylam Pharmaceuticals, Inc. Company Details
Table 70. Alnylam Pharmaceuticals, Inc. Business Overview
Table 71. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 72. Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 73. Alnylam Pharmaceuticals, Inc. Recent Developments
Table 74. Applied Genetic Technologies Corporation Company Details
Table 75. Applied Genetic Technologies Corporation Business Overview
Table 76. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product
Table 77. Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 78. Applied Genetic Technologies Corporation Recent Developments
Table 79. Arrowhead Pharmaceuticals, Inc. Company Details
Table 80. Arrowhead Pharmaceuticals, Inc. Business Overview
Table 81. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 82. Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 83. Arrowhead Pharmaceuticals, Inc. Recent Developments
Table 84. Carolus Therapeutics, Inc. Company Details
Table 85. Carolus Therapeutics, Inc. Business Overview
Table 86. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 87. Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 88. Carolus Therapeutics, Inc. Recent Developments
Table 89. Cevec Pharmaceuticals GmbH Company Details
Table 90. Cevec Pharmaceuticals GmbH Business Overview
Table 91. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product
Table 92. Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 93. Cevec Pharmaceuticals GmbH Recent Developments
Table 94. Dicerna Pharmaceuticals, Inc. Company Details
Table 95. Dicerna Pharmaceuticals, Inc. Business Overview
Table 96. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 97. Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 98. Dicerna Pharmaceuticals, Inc. Recent Developments
Table 99. Digna Biotech, S.L. Company Details
Table 100. Digna Biotech, S.L. Business Overview
Table 101. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product
Table 102. Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 103. Digna Biotech, S.L. Recent Developments
Table 104. Editas Medicine, Inc. Company Details
Table 105. Editas Medicine, Inc. Business Overview
Table 106. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 107. Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 108. Editas Medicine, Inc. Recent Developments
Table 109. Grifols, S.A. Company Details
Table 110. Grifols, S.A. Business Overview
Table 111. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product
Table 112. Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 113. Grifols, S.A. Recent Developments
Table 114. Inhibrx Company Details
Table 115. Inhibrx Business Overview
Table 116. Inhibrx Alpha- Antitrypsin Deficiency Treatment Product
Table 117. Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 118. Inhibrx Recent Developments
Table 119. Intellia Therapeutics, Inc. Company Details
Table 120. Intellia Therapeutics, Inc. Business Overview
Table 121. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 122. Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 123. Intellia Therapeutics, Inc. Recent Developments
Table 124. International Stem Cell Corporation Company Details
Table 125. International Stem Cell Corporation Business Overview
Table 126. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product
Table 127. International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 128. International Stem Cell Corporation Recent Developments
Table 129. Ionis Pharmaceuticals, Inc. Company Details
Table 130. Ionis Pharmaceuticals, Inc. Business Overview
Table 131. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 132. Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 133. Ionis Pharmaceuticals, Inc. Recent Developments
Table 134. Kamada Ltd. Company Details
Table 135. Kamada Ltd. Business Overview
Table 136. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product
Table 137. Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 138. Kamada Ltd. Recent Developments
Table 139. Polyphor Ltd. Company Details
Table 140. Polyphor Ltd. Business Overview
Table 141. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product
Table 142. Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 143. Polyphor Ltd. Recent Developments
Table 144. ProMetic Life Sciences Inc. Company Details
Table 145. ProMetic Life Sciences Inc. Business Overview
Table 146. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 147. ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 148. ProMetic Life Sciences Inc. Recent Developments
Table 149. rEVO Biologics, Inc. Company Details
Table 150. rEVO Biologics, Inc. Business Overview
Table 151. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 152. rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 153. rEVO Biologics, Inc. Recent Developments
Table 154. Sangamo BioSciences, Inc. Company Details
Table 155. Sangamo BioSciences, Inc. Business Overview
Table 156. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 157. Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 158. Sangamo BioSciences, Inc. Recent Developments
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Type: 2021 VS 2028
Figure 2. CT-2009 Features
Figure 3. POL-6014 Features
Figure 4. ARO-AAT Features
Figure 5. ALNAAT-02 Features
Figure 6. Others Features
Figure 7. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application: 2021 VS 2028
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Alpha- Antitrypsin Deficiency Treatment Report Years Considered
Figure 12. Global Alpha- Antitrypsin Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Alpha- Antitrypsin Deficiency Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Players in 2021
Figure 16. Global Top Alpha- Antitrypsin Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha- Antitrypsin Deficiency Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Alpha- Antitrypsin Deficiency Treatment Revenue in 2021
Figure 18. North America Alpha- Antitrypsin Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Alpha- Antitrypsin Deficiency Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Alpha- Antitrypsin Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size Share by Region (2017-2028)
Figure 38. China Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Adverum Biotechnologies, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 58. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 59. Applied Genetic Technologies Corporation Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 60. Arrowhead Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 61. Carolus Therapeutics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 62. Cevec Pharmaceuticals GmbH Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 63. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 64. Digna Biotech, S.L. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 65. Editas Medicine, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 66. Grifols, S.A. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 67. Inhibrx Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 68. Intellia Therapeutics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 69. International Stem Cell Corporation Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 70. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 71. Kamada Ltd. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 72. Polyphor Ltd. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 73. ProMetic Life Sciences Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 74. rEVO Biologics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 75. Sangamo BioSciences, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Industry Market Size
